Recent Analysts’ Ratings Changes for Colgate-Palmolive (CL)

Colgate-Palmolive (NYSE: CL) has recently received a number of price target changes and ratings updates:

• 11/3/2026 – Colgate-Palmolive had its price target raised by Barclays from $87.00 to $95.00. They now have an “equal weight” rating on the stock.
• 11/2/2026 – Colgate-Palmolive had its price target raised by TD Cowen from $90.00 to $97.00. They now have a “hold” rating on the stock.
• 11/2/2026 – Colgate-Palmolive had its price target raised by Bank of America from $100.00 to $105.00. They now have a “buy” rating on the stock.
• 11/2/2026 – Colgate-Palmolive had its price target raised by UBS Group from $106.00 to $112.00. They now have a “buy” rating on the stock.
• 11/2/2026 – Colgate-Palmolive had its “outperform” rating reaffirmed by BNP Paribas Exane. They now have a $108.00 price target on the stock, up from $97.00.
• 11/2/2026 – Colgate-Palmolive had its price target raised by Morgan Stanley from $104.00 to $111.00. They now have an “overweight” rating on the stock.
• 11/2/2026 – Colgate-Palmolive had its price target lowered by JPMorgan Chase & Co. from $104.00 to $102.00. They now have an “overweight” rating on the stock.
• 11/2/2026 – Colgate-Palmolive had its price target raised by Royal Bank Of Canada from $104.00 to $105.00. They now have an “outperform” rating on the stock.
• 11/2/2026 – Colgate-Palmolive had its price target raised by Wells Fargo & Company from $90.00 to $95.00. They now have an “equal weight” rating on the stock.
• 10/19/2026 – Colgate-Palmolive had its price target raised by JPMorgan Chase & Co. from $103.00 to $104.00. They now have an “overweight” rating on the stock.
• 10/15/2026 – Colgate-Palmolive was given a new $106.00 price target by UBS Group.
• 10/9/2026 – Colgate-Palmolive had its price target lowered by Bank of America from $102.00 to $100.00. They now have a “buy” rating on the stock.
• 10/8/2026 – Colgate-Palmolive had its price target raised by Evercore from $100.00 to $101.00. They now have an “outperform” rating on the stock.
• 10/5/2026 – Colgate-Palmolive had its price target lowered by Wells Fargo & Company from $95.00 to $90.00. They now have an “equal weight” rating on the stock.
• 10/2/2026 – Colgate-Palmolive was downgraded by Weiss Ratings from “buy (b-)” to “hold (c+)”.
• 9/28/2026 – Colgate-Palmolive had its price target lowered by BNP Paribas Exane from $101.00 to $97.00. They now have an “outperform” rating on the stock.
• 9/21/2026 – Colgate-Palmolive had its price target lowered by Piper Sandler from $98.00 to $95.00. They now have an “overweight” rating on the stock.
• 9/16/2026 – Colgate-Palmolive was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.

Colgate-Palmolive Stock Down 0.1%

Shares of NYSE CL opened at $97.98 on Thursday. Colgate-Palmolive Company has a one year low of $75.96 and a one year high of $101.18. The company has a debt-to-equity ratio of 11.23, a current ratio of 0.96 and a quick ratio of 0.63. The business’s fifty day moving average price is $90.59 and its 200-day moving average price is $90.16. The stock has a market capitalization of $77.89 billion, a PE ratio of 38.42, a P/E/G ratio of 4.44 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.04. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The company had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.34 billion. During the same quarter in the prior year, the company earned $0.91 EPS. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. On average, equities research analysts anticipate that Colgate-Palmolive Company will post 3.92 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 83.14%.

Insider Transactions at Colgate-Palmolive

In other news, CEO Noel Wallace sold 20,000 shares of Colgate-Palmolive stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $100.26, for a total value of $2,005,200.00. Following the completion of the transaction, the chief executive officer owned 359,700 shares in the company, valued at $36,063,522. This trade represents a 5.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Panagiotis Tsourapas sold 19,938 shares of the business’s stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $98.74, for a total transaction of $1,968,678.12. Following the completion of the sale, the chief operating officer directly owned 9,111 shares in the company, valued at approximately $899,620.14. This trade represents a 68.64% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 73,314 shares of company stock worth $7,212,109 over the last quarter. Corporate insiders own 0.43% of the company’s stock.

Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.